INTRODUCTION
In 2001, the Stages of Reproductive Aging Workshop (STRAW) defined 'perimenopause' as the period beginning with menopausal transition and ending 12 months after the last menstrual period. 1, 2 This may last for 4-8 years. During this period, the endocrinological, biological and clinical features of approaching menopause commence. The perimenopause is often characterised by menstrual cycle irregularities in frequency and volume, due to fluctuating estrogen levels. These changes are unpredictable and are unique for each woman. Although irregular bleeding patterns are a normal and expected part of perimenopause, the incidence of uterine pathology and associated medical complications also increase in this age group. 3 Of equal importance is the impact of this abnormal blood loss on the quality of the woman's life. AUB in the perimenopausal period assumes significance. AUB accounts for about 70% of all gynaecologic outpatient visits in the perimenopausal women. 4 The TVUS is a simple and non-invasive diagnostic modality of studying the endometrial pattern and its thickness accurately, and at the same time to exclude organic pathology in cases of AUB. The high frequency transducer placed nearer to the region of interest permits better visualisation of the uterus and the endometrium. 5 D&C is a simple day case procedure for histological evaluation of the endometrium and remains the standard diagnostic procedure for the assessment of abnormal uterine bleeding and for early detection of precancerous lesions like atypical endometrial hyperplasia. It was once considered as the gold standard of investigating patients with AUB, but it has the drawback of being a blind procedure with a chance of missing a small or focal lesion. 6 However, together with TVUS the D&C still remains a very cost effective, practical and dependable approach for investigating AUB. In addition, accurate histopathological diagnosis also facilitates the implementation of optimal treatment strategies. The present study aims to correlate the clinical findings with sonographic assessment and histopathology of the endometrium.
METHODS
The work presented in this article is a retrospective study conducted at Cochin Medical College -a tertiary level teaching hospital in Cochin, Kerala, India. A random sample of 88 women in the perimenopausal age group of 40 to 51 years was included in the study. These women reported with AUB during the period June 2012 to November 2013.
Detailed history of menstrual abnormalities, duration of complaints, obstetric, medical, surgical history and details of previous treatment taken were noted. All the women were clinically evaluated -general, systemic and gynaecological examinations were carried out. All relevant investigations and pre-anaesthetic check-ups were done.
TVUS was performed in all these women using ultrasonography machine GE LOGIQ 500 MD MR3 and a vaginal probe of 7.5 MHz. Endometrial thickness was measured as maximal double layer thickness in midsagittal section at the thickest area of the endometrium near the fundus, including the outermost border of both sides of the endometrium. All the scans were performed by experienced sonologists in the medical college. A D&C and HPE of the endometrium were scheduled within 24 -48 hr of the TVUS as an inpatient procedure. The menstrual abnormalities were correlated with the endometrial thickness on TVUS and the histopathology report and the results were analysed. Table 1 shows the age wise distribution of patients. Patients in the age group 40 -51 were studied. There was almost equal distribution of patients in the 44 -47 and 48 -51 age group. The study was carried out in Kerala where there is a high degree of acceptance of family planning methods. Hence, 70.45% of patients were para 2 or less ( Table 2) . The majority of women (46.6%) presented with menorrhagia and 19% with menometrorrhagia. The most common associated symptom was dysmenorrhoea. 15% of patients presented with features of metropathiaperiods of amenorrhoea of 3 to 6 months followed by prolonged heavy bleeding, a feature most characteristic of perimenopausal anovulatory cycles (Table 3) . On clinical examination and ultrasonographic confirmation 55.7% of patients presented with fibroid uterus, 29.5% of cases had no obvious organic pathology, i.e., dysfunctional uterine bleeding while in 7.9% of cases the cause was endometrial polyp (Table 4) .
RESULTS
TVUS examination revealed 41 out of the 88 patients to have endometrial thickness between 5 and 9.9 mm, thus accounting for 46.6% of patients. 22.7% patients had endometrial thickness between 10 and 14.9 mm (Table  5) . (Table 6 ). When the presenting menstrual complaints of the patients were correlated with their histopathological examination report, it was found that out of the 41 patients who presented with menorrhagia, 15 had proliferative endometrium and 8 showed disordered proliferation of endometrium, thus making proliferative endometrium the most common finding in menorrhagia. Among the 15 patients with metropathia, 7 showed hyperplastic changes of which 4 were complex hyperplasia with atypia (Table  7) . (Table 8) . In 3 patients, endometrial tissue was found to be inadequate for diagnosis. 
DISCUSSION
As AUB is the problem responsible for most of the gynaecologic consultations in the perimenopausal age group, thorough evaluation is a must especially in this age group to rule out endometrial cancer or its precursor lesion -endometrial hyperplasia. Sonographic and histological assessment of the endometrium is the corner stone of diagnosis in the current practice.
In the present study menorrhagia was the most common clinical presentation seen in 46.5% of cases followed by menometrorrhagia at 21.5% which is very similar to the study by Jetley et al. in which they studied 219 perimenopausal women in New Delhi. 7 Proliferative endometrium was the most common finding on histopathological examination. The mean endometrial thickness was 7.45 mm in the proliferative phase and 12.45 mm in the secretory phase. These findings are consistent with similar studies carried out by Acharya Veena et al. in 2003. 8 In the earlier mentioned study by Jetley et al. 7 however, secretory endometrium was the most common finding at 32.4% followed by proliferative endometrium. In the present study, complex hyperplasia with atypia or malignancy was not noted at endometrial thickness less than 14.9 mm. All the 9 cases that showed abnormality on histopathological evaluation had endometrial thickness greater than 15 mm. This study thus corroborated the findings of similar study done by Aliya Aslam et al. in 2009 . 9 Their study found that no major endometrial pathology is detected when endometrial thickness is less than 14 mm. Study by Machado et al in 2005 concluded that endometrial thickness less than 5 mm did not need D&C as none of these patients had atypia or malignancy which is also corroborated in the present study.
10,11
The study by Chatapavit et al. concluded that endometrial thickness of 8 mm or less is less likely to be associated with malignant pathology in perimenopausal women with abnormal uterine bleeding. 12 There is no clear definition of what constitutes an abnormal endometrial thickness in the still menstruating perimenopausal woman. The upper limit for normal endometrial thickness remains controversial, but most studies have reported transvaginal sonographic endometrial thickness.8 mm as the abnormal cut off value, necessitating further investigations. 13 In the perimenopausal cycles, there is unopposed estrogen stimulation which leads to hyperplasia of the endometrium which can progress to endometrial cancer. History of irregular cycles, polycystic ovarian syndrome, and anovulatory cycles are risk factors in the progression of endometrial hyperplasia. The risk of development of endometrial cancer is 29% in patients with complex atypical hyperplasia and 2% in patients with hyperplasia but without atypia.
14 This is to emphasise the fact that all patients with endometrial hyperplasia diagnosed on TVUS must have a thorough endometrial evaluation by D&C. 15, 16 In 3 patients, the endometrial curettings were scanty and reported as inadequate for diagnosis. In a study conducted at the School of Medicine, Philadelphia, the negative predictive value of endometrial tissue reported as inadequate for endometrial neoplasia was determined. This study concluded that inadequate endometrial sample can be considered to rule out endometrial neoplasia because of its high negative predictive value.
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CONCLUSIONS
In perimenopausal women presenting with AUB, a speculum examination and palpation should always be performed first.
TVUS is recommended as a first line diagnostic tool as it is relatively inexpensive, safe and non-invasive. It will not only reveal endometrial thickness but also other pelvic pathology.
The primary indication for invasive methods like D&C should be in cases with abnormal thickness of endometrium >8mm or inconclusive TVUS in order to obtain endometrial tissue to exclude precancerous lesion or endometrial cancer.
